AbbVie’s ABBV stock has declined 8% in the past three months. A lot of this price decline is due to the poor performance of ...

The race to develop new weight-loss drugs has been heating up. Earlier this week ... LLY stock holds a Relative Strength Rating of 41 out of a best-possible 99, IBD Digital shows. Eli Lilly stock also ...

Technology Networks spoke with Dr. Thomas Dennison, University of Cambridge, to learn more about the advantages of using ...

The company will protect the branded anti-interleukin (IL)-12/23 biologic against sales erosion from pending biosimilars.

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in H2 2025 Phase 2 trial of VTX2735 in participants with ...

Emulsifiers — found in many packaged foods such as candy, salad dressings, and baked goods — have been linked to bodily ...

Phase 1 healthy volunteer trial ongoing, with data expected in 2Q25Kymera plans to initiate a KT-621 Phase 1b trial in atopic ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 503.77% and ...

A loss-of-function mutation to the PTPN2 gene, commonly associated with autoimmune diseases, can make cells more susceptible ...

Aaron Kinsey and Juliette Reeves discuss research on the oral microbiome which is informing a more holistic approach to ...

Yes. Attendance Allowance isn't means-tested so it doesn't matter what other money you have coming in or how much you have in ...